Morning Bid: Quantum leap

Pulte is widely viewed as a Trump loyalist who has targeted the president's political foes during his tenure leading the housing regulatory agency.

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

Marco Papic is worried about where stocks are headed in six to 12 months from now, with massive tech IPOs a big part of that concern.

Unlike prior months, where job growth was concentrated in healthcare and a few other sectors, gains were more broad-based.